- Home
- VBFC vs ANL Comparison
VBFC vs ANL Comparison
Compare VBFC & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VBFC
- ANL
- Stock Information
- Founded
- VBFC 1999
- ANL 2004
- Country
- VBFC United States
- ANL Cayman Islands
- Employees
- VBFC N/A
- ANL 127
- Industry
- VBFC Major Banks
- ANL
- Sector
- VBFC Finance
- ANL
- Exchange
- VBFC Nasdaq
- ANL Nasdaq
- Market Cap
- VBFC 116.5M
- ANL 115.1M
- IPO Year
- VBFC N/A
- ANL 2023
- Fundamental
- Price
- VBFC $77.90
- ANL $3.12
- Analyst Decision
- VBFC
- ANL Strong Buy
- Analyst Count
- VBFC 0
- ANL 2
- Target Price
- VBFC N/A
- ANL $9.00
- AVG Volume (30 Days)
- VBFC 478.0
- ANL 29.1K
- Earning Date
- VBFC 10-25-2024
- ANL 08-08-2024
- Dividend Yield
- VBFC 0.92%
- ANL N/A
- EPS Growth
- VBFC 204.00
- ANL N/A
- EPS
- VBFC 4.89
- ANL N/A
- Revenue
- VBFC $32,098,999.00
- ANL $5,000,000.00
- Revenue This Year
- VBFC N/A
- ANL N/A
- Revenue Next Year
- VBFC N/A
- ANL N/A
- P/E Ratio
- VBFC $15.93
- ANL N/A
- Revenue Growth
- VBFC 24.96
- ANL N/A
- 52 Week Low
- VBFC $36.08
- ANL $1.85
- 52 Week High
- VBFC $77.90
- ANL $17.48
- Technical
- Relative Strength Index (RSI)
- VBFC 85.97
- ANL 64.09
- Support Level
- VBFC $76.50
- ANL $2.88
- Resistance Level
- VBFC $76.95
- ANL $3.50
- Average True Range (ATR)
- VBFC 0.10
- ANL 0.41
- MACD
- VBFC -0.41
- ANL 0.12
- Stochastic Oscillator
- VBFC 100.00
- ANL 60.19
About VBFC Village Bank and Trust Financial Corp.
Village Bank and Trust Financial Corp is a bank holding company. The banking is the primary operating business of the company. It offers a range of banking and related financial services, including checking, savings, certificates of deposit and other depository services, and commercial, real estate, and consumer loans, primarily in the Richmond, Virginia and Williamsburg, Virginia metropolitan areas. Its operating segment includes Commercial Banking and Mortgage Banking. The company generates maximum revenue from the Commercial Banking segment, which provides the mortgage banking segment with the short-term funds needed to originate mortgage loans through a warehouse line of credit and charges the mortgage banking segment interest based on the commercial banking segment's cost of funds.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.